MPN Hero Advocates For Patients Enrolled In Clinical Trials


Kurt Schroeder, a research nurse, pushes for a patient-first mentality, especially as they participate in a clinical trial.

When asked why he likes working with patients with myeloproliferative neoplasms (MPNs), Kurt Schroeder, RN, responded with “I like working with my people.”

Schroeder, a research nurse at The University of Texas MD Anderson Cancer Center, advocates for patients amid researchers that sometimes forget they are dealing with people. Those efforts were recognized during the 2019 MPN Heroes® ceremony where he was awarded for his patient advocacy work.

At the event, CURE® had the chance to speak with Schroeder about how he makes sure patients enrolled in clinical research are given the proper treatment and, in one instance, had their treatment altered as needed to limit side effects.


Other particulars of some of the studies include common medications. Sometimes the QT interval medications someone will pull that out of the air, it seems like some of the medications shouldn't necessarily probably be on the list because we’ll take transfusion requirements.

For instance, a lot of facilities where physicians will pretreat the patients before they get a transfusion with Benadryl — and Benadryl on some of the sites is listed as a QTC medication which could affect with a patient's heartbeat, but they exclude it by the protocol by a list of prohibited medications.

So I've discussed with the physician investigator before about adjusting the medication list or maybe the Benadryl could have a particular dose that they're allowed to have, and beyond that, then that dose would be excluded. So it makes it a little bit less disruptive and has less deviations to the study if they update the list.

Related Videos
Jessica McDade, B.S.N., RN, OCN, in an interview with CURE
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
A man with a dark gray button-up shirt with glasses and cropped brown hair.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE